Fortress Biotech Income Statement (2013-2025) | FBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	11.59M	15.29M	19.61M	17.52M	23.93M	0.58M	16.53M	0.36M	12.43M	0.18M	0.18M	40.11M	13.03M	14.90M	14.63M	12.58M	13.14M	16.41M	17.63M	18.09M
Gross Profit (Quarter)	7.68M	7.80M	8.44M	7.99M	15.72M	-7.06M	9.31M	-7.35M	5.98M	-7.58M	-6.25M	37.86M	7.03M	9.17M	10.16M	7.90M	8.35M	11.47M	11.88M	12.65M
Operating items
Amortization - Intangibles (Quarter)													0.81M	0.81M	0.81M	0.98M	1.06M	1.06M	1.06M	1.11M
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)	20.15M	33.83M	27.37M	58.64M	36.72M	33.13M	29.90M	35.17M	35.28M	32.14M	20.29M	14.04M	24.84M	12.67M	9.45M	9.69M	3.94M	8.13M	0.21M	-0.37M
Wages, Salaries and Other (Quarter)
Selling, General & Administrative (Quarter)	17.54M	19.38M	22.22M	27.70M	26.27M	29.05M	30.14M	28.20M	25.34M	24.44M	21.73M	19.47M	17.94M	20.82M	21.99M	26.86M	25.66M	38.76M	17.41M	14.73M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	3.91M	7.48M	21.42M	-6.06M	8.20M	7.63M	7.22M	7.67M	10.68M	10.91M	1.40M	6.05M	6.82M	9.19M	5.29M	2.40M	5.86M	6.00M	6.82M	6.50M
Operating Expenses (Quarter)	41.60M	60.70M	71.01M	80.28M	71.19M	69.81M	67.26M	71.04M	71.30M	67.49M	48.51M	39.56M	49.60M	42.68M	36.72M	38.95M	35.46M	52.89M	24.44M	20.87M
Operating Income (Quarter)	-30.02M	-42.86M	-49.92M	-62.00M	-47.27M	-50.93M	-50.73M	-54.63M	-58.87M	-50.10M	-13.76M	-19.61M	-36.57M	-27.79M	-22.09M	-23.84M	-22.32M	-36.47M	-6.81M	58.41M
EBIT (Quarter)	-30.02M	-42.86M	-49.92M	-62.00M	-47.27M	-50.93M	-50.73M	-54.63M	-58.87M	-50.10M	-13.76M	-19.61M	-36.57M	-27.79M	-22.09M	-23.84M	-22.32M	-36.47M	-6.81M	58.41M
Non-operating items
Interest & Investment Income (Quarter)	0.23M	0.15M	0.13M	0.14M	0.14M	0.15M	0.42M	0.69M	1.04M	0.71M	0.55M	0.71M	0.83M	0.73M	0.59M	0.53M	0.49M	0.62M	0.74M	0.64M
Other Non Operating Income (Quarter)							0.65M	0.57M	0.30M	0.40M	0.62M	-1.35M	-0.02M	0.28M	1.07M	-0.02M	-0.01M	-0.06M	17.67M	-0.02M
Non Operating Income (Quarter)	3.95M	18.47M	4.06M	-6.03M	-2.21M	-3.00M	0.65M	8.75M	3.72M	0.40M	3.17M	-1.35M	-2.46M	0.28M	1.07M	-2.14M	-2.37M	-0.06M	15.66M	-1.42M
Net income details
EBT (Quarter)	-29.79M	-42.71M	-50.19M	-61.86M	-47.13M	-50.78M	-53.06M	-57.00M	-57.83M	-49.49M	-10.58M	-28.61M	-35.83M	-27.15M	-26.62M	-25.98M	-21.83M	-35.85M	8.85M	-6.21M
Tax Provisions (Quarter)				0.47M				0.40M			0.10M	0.15M			0.07M	0.32M			0.03M	-0.70M
Profit After Tax (Quarter)	-8.82M	-3.54M	-45.86M	-68.51M	-17.80M	-21.40M	-22.51M	-57.45M	-21.54M	-59.30M	-5.04M	-28.98M	-39.02M	-28.82M	-26.69M	-26.32M	-10.58M	-11.65M	8.83M	-43.67M
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	-17.24M	-20.86M	-25.08M	-36.94M	33.72M	-32.57M	30.55M	30.50M	33.61M	34.52M	5.68M	19.70M	-23.61M	17.88M	-13.83M	19.55M	-14.11M	-27.14M	2.98M	78.00M
Income from Continuing Operations (Quarter)	-29.79M	-42.71M	-50.19M	-62.33M	-47.13M	-50.78M	-53.06M	-57.40M	-57.83M	-49.49M	-10.68M	-28.76M	-35.83M	-27.15M	-26.69M	-26.30M	-21.83M	-35.85M	8.83M	-5.51M
Consolidated Net Income (Quarter)	-29.79M	-42.71M	-50.19M	-62.33M	-47.13M	-50.78M	-53.06M	-57.40M	-57.83M	-49.49M	-10.68M	-28.76M	-35.83M	-27.15M	-26.69M	-26.30M	-21.83M	-35.85M	8.83M	-5.51M
Income towards Parent Company (Quarter)	-29.79M	-42.71M	-50.19M	-62.33M	-47.13M	-50.78M	-53.06M	-57.40M	-57.83M	-49.49M	-10.68M	-28.76M	-35.83M	-27.15M	-26.69M	-26.30M	-21.83M	-35.85M	8.83M	-5.51M
Preferred Dividend Payments (Quarter)						2.01M	2.01M	2.01M		2.01M	2.01M	2.01M	2.44M		2.17M	2.89M	2.13M		2.17M	2.26M
Net Income towards Common Stockholders (Quarter)	-29.79M	-42.71M	-50.19M	-62.33M	-47.13M	-23.36M	-24.52M	-28.95M	-23.55M	-26.92M	-7.05M	-11.29M	-17.86M	-13.34M	-15.04M	-9.65M	-12.71M	13.36M	3.67M	-6.20M
Additional items
EPS (Basic) (Quarter)	-0.11	-0.04	-0.26	-0.38	-0.21	-0.26	-4.11	-4.82	-3.47	-3.65	-0.94	-0.53	-1.04	-0.73	-0.76	-0.26	-0.48	0.50	0.13	-0.23
EPS (Weighted Average and Diluted) (Quarter)	-0.11	-0.04	-0.26	-0.38	-0.18	-0.26	-4.11	-4.82	-0.21	-3.65	-0.94	-0.53	-1.04	-0.73	-0.76	-0.26	-0.48	0.45	0.11	-0.21
Shares Outstanding (Weighted Average) (Quarter)	4.53M	80.96M	81.06M	0.30M	4.42M	88.74M	5.96M	0.13M	6.79M	1.91M	0.13M	5.79M	17.15M	17.74M	19.70M	14.41M	26.45M	26.88M	27.08M	13.43M
Shares Outstanding (Diluted Average) (Quarter)	80.85M	80.91M	81.35M	81.70M	86.26M	87.59M	5.89M	5.92M	101.89M	7.38M	7.23M	8.11M	17.15M	17.74M	19.70M	20.78M	26.45M	29.18M		27.90M
EBITDA (Quarter)	-30.02M	-42.86M	-49.92M	-62.00M	-47.27M	-50.93M	-50.73M	-54.63M	-58.87M	-50.10M	-13.76M	-19.61M	-36.57M	-27.79M	-22.09M	-23.84M	-22.32M	-36.47M	-6.81M	58.41M
Interest Expenses (Quarter)			0.40M							0.10M	0.10M	0.10M	0.10M	0.10M
Shares Outstanding (Quarter)	3.43M	97.50M	0.36M	6.76M	106.32M	7.18M	668.75M	7.37M	8.69M	3.43M	8.94M	15.09M	3.43M	22.59M	27.58M	27.91M	29.55M	29.75M	31.01M	31.36M
Tax Rate (Quarter)				-0.76				-0.70			-0.94	-0.54			-0.26	-1.25			0.29	11.23

Research Tools

Fortress Biotech Income Statement (2013-2025) | FBIO

Create an account

Sign In

Reset Password